Managed Healthcare Executive

2 days ago | managedhealthcareexecutive.com | Jared Kaltwasser

It’s been 8 1/2 years since the CMS first announced its value-based insurance design (VBID) pilot for Medicare Advantage programs. At the time, the agency said the program would give Medicare Advantage plans the flexibility to design plans that incentivize patients to use high-value care.

3 days ago | managedhealthcareexecutive.com | Jared Kaltwasser

Newly discovered mechanisms associated with chronic muscle inflammation in Duchenne muscular dystrophy (DMD) could point the way to new therapeutic options to slow progressive muscle weakness in patients. If validated in future studies, the findings suggest that currently available therapies might be repurposed to help preserve muscle function in patients with the disease. DMD is marked by progressive muscle degeneration and weakness, eventually leading to loss of ambulation.

4 days ago | managedhealthcareexecutive.com | Peter Wehrwein

June 2, 2025By MHE PublicationMHE June 2025Gary M. Owens, M.D., is a medical and pharmacy management consultant in Ocean View, Delaware, with experience working for health insurers and as a family physician. Lawrence Eichenfield, M.D., is chief of pediatric and adolescent dermatology at Rady Children’s Hospital-San Diego and professor of dermatology and pediatrics and vice-chair of the department of dermatology at UC San Diego School of Medicine in California.

4 days ago | managedhealthcareexecutive.com | Peter Wehrwein

June 2, 2025By MHE PublicationMHE June 2025Kimber Simmons, M.D., M.S., is an associate professor at the University of Colorado School of Medicine who specializes in the genetic, metabolic and immunologic diversity of autoimmune diseases, with a primary focus on Type 1 diabetes. In this Managed Healthcare Executive K-Cast video series, Simmons discusses the epidemiology of Type 1 diabetes, its causes, screening and early detection, treatment and future research.

4 days ago | managedhealthcareexecutive.com | Peter Wehrwein

June 2, 2025By MHE PublicationMHE June 2025Eric K. Singhi, M.D., is an assistant professor in the Department of Thoracic/Head and Neck Medical Oncology at The University of Texas MD Anderson Cancer Center in Houston, and Ben Creelan, M.D., is a medical oncologist and clinical researcher in the Department of Thoracic Oncology at the Moffitt Cancer Center in Tampa, Florida.